Ming Kuang

In this session, you will learn about the advances in microbial biotransformation of drugs and this can impact clinical outcomes and adverse events…

BACKGROUND: Non-alcoholic steatohepatitis (NASH), a leading cause of liver-related morbidity and mortality, is highly prevalent in people living with HIV (PLWH).1 Microbial translocation (MT) associated with hepatic inflammation and fibrosis may play a critical role in NASH pathogenesis…

Intrahepatic cholangiocarcinoma (ICC) is an aggressive and heterogeneous malignancy derived from biliary tract in liver, with increasing incidence and mortality rates worldwide, dismal prognosis and limited treatment options. Novel effective therapeutic strategies are urgently needed…

BACKGROUND & AIMS: Gut microbiota plays an important regulatory role in tumor progression. Previous studies have shown that there are bacteria in hepatocellular carcinoma (HCC). However, the role of these bacteria in the development and progression of HCC remains unclear…

BACKGROUND & AIM: About half of patients with hepatocellular carcinoma (HCC) are initially diagnosed with multi-nodule, which developed either from intrahepatic metastasis (IM) or multicentric occurrence (MO)…

BACKGROUND AND AIMS: Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer whose incidence is increasing globally. Majority of ICC patients are diagnosed at an advanced stage with limited treatment options…